Jade Biosciences, Inc.
Clinical trials sponsored by Jade Biosciences, Inc., explained in plain language.
-
New hope for kidney disease: JADE101 trial launches
Disease control Not yet recruitingThis study tests a new drug called JADE101 in 30 adults with IgA nephropathy, a kidney disease. The goal is to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Participants must be on stable blood pressure medication and have a certain level o…
Phase: PHASE2 • Sponsor: Jade Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New RA drug JADE201 enters first human safety trial
Symptom relief Not yet recruitingThis early-stage study tests a new drug, JADE201, in 36 adults with rheumatoid arthritis. The main goal is to see if single doses are safe and how the body processes the drug. Participants will receive either JADE201 or a placebo by injection, and researchers will monitor side ef…
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Symptom relief
Last updated May 18, 2026 12:11 UTC